Emery Pharma Exhibiting at the 2023 AAPS Annual Meeting in Orlando, Florida
Alameda, CA – Emery Pharma is excited to announce its participation as an exhibitor at the American Association of Pharmaceutical Scientists (AAPS) Conference, scheduled to be held on October 22-25, 2023, at the Orange County Convention Center in Orlando, Florida.
Enhanced Capabilities in Biologics Characterization
This year, Emery Pharma is set to unveil its enhanced capabilities with a focus on biologics characterization. As the pharmaceutical industry continues to evolve, biologics play an increasingly critical role in drug development. Emery Pharma’s expertise in this area is poised to make a significant impact. Our team will be readily available to engage in discussions, answer inquiries, and conduct one-on-one meetings with esteemed conference attendees.
Emery Pharma’s scientific team has a deep understanding of biologics characterization, which enables the company to provide comprehensive support in areas such as analytical and bioanalytical solutions, cell biology services, and drug and impurity characterization.
Utilizing Cutting-Edge Bioanalytical and Analytical Techniques
Emery Pharma leverages state-of-the-art techniques to provide unparalleled insights into drug development and biologics characterization, including:
High-Resolution Mass Spectrometry (HRMS): Leveraging a newly acquired Thermo Scientific™ Exploris 240 UPLC-MS system with the Biopharma option, Emery Pharma is able to offer an unprecedented mass range for intact mass analyses (m/z up to 8000). This advanced technique is particularly valuable for identifying and quantifying metabolites for trace-level compounds.
Liquid Chromatography Mass Spectrometry (LCMS): Their MS capabilities allow for precise and detailed analysis of drug compounds, metabolites, and their interactions within biological systems. This powerful technique enables Emery Pharma’s team to identify, quantify, and characterize compounds with high sensitivity and specificity, making it an indispensable tool in pharmaceutical research.
Nuclear Magnetic Resonance (NMR): NMR spectroscopy is a cornerstone of Emery Pharma’s offerings. It provides unique structural and dynamic information about molecules, including biologics. With NMR, we can elucidate the three-dimensional structures of complex compounds, study molecular interactions, and gain crucial insights into drug design and formulation. Emery Pharma provides cGMP-GLP (Current Good Manufacturing Practice-Good Laboratory Practice) NMR services with their in-house qualified 400 MHz instrument.
Event: 2023 AAPS Annual Meeting: PharmSci 360
Location: Orange County Convention Center in Orlando, Florida
Date: October 22-25, 2023
Place: Booth #3352
The Emery Pharma team is eager to share insights, exchange ideas, and explore potential collaborations during the event!
About Emery Pharma: Emery Pharma is a full-service contract research laboratory, supporting the end-to-end development of small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more. Emery Pharma specializes in supporting preclinical drug development, including analytical, bioanalytical solutions, microbiology & cell biology services, drug & impurity characterization, and general R&D and cGMP/GLP support. https://emerypharma.com/contact/
Stay connected with Emery Pharma: Emery Pharma looks forward to connecting with attendees!
Contact us at: +1-510-899-8814 or 1-888-983-6379